Simcere (å 声å¶čÆ) IPO Trading: Mind the Sentiment Changes
We are of the view that the deal will not perform well compared to previous hot biotech deals as it is fairly valued and the sentiment is weak for...
621 Views
ECM Weekly (18 October 2020) - Lufax, Simcere, KWG Living, GDS, Jacobio
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. This week...
559 Views
Simcere Pharmaceutical IPO: Valuation Insights
We think that an attractive PEG valuation and solid cornerstone support makes Simcere tempting at the proposed pricing range
566 Views
Simcere (å 声å¶čÆ) IPO: Fairly Valued for a Generic Player
We think the company is fairly valued but will participate in the deal given the likely strong sentiment as the deal is backed by decent...
466 Views
ECM Weekly (11 October 2020) - Excellence Comm, MR DIY, Converge ICT, Simcere, SciClone, JW Thera
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming...
602 Views